RAC 2.20% $1.78 race oncology ltd

Ann: Bisantrene Shows Broad Anti-Cancer Activity in Cancer Cells, page-155

  1. 17,638 Posts.
    lightbulb Created with Sketch. 434
    yes you are a shareholder like the rest of holders however you are the “major” shareholder ( I believe) and a consultant to the company so I would assume you have more insight than the other shareholders
 
watchlist Created with Sketch. Add RAC (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.